ASCO 2023 – Bicara Eyes Head And Neck Niche
Impressive data in HPV-negative disease, potentially beating Keytruda, has the private group making pivotal plans.
Impressive data in HPV-negative disease, potentially beating Keytruda, has the private group making pivotal plans.